IL61575A - 4(5),13(14)-diunsaturated 16-hydroxy-prostanoic acid derivatives - Google Patents

4(5),13(14)-diunsaturated 16-hydroxy-prostanoic acid derivatives

Info

Publication number
IL61575A
IL61575A IL61575A IL6157580A IL61575A IL 61575 A IL61575 A IL 61575A IL 61575 A IL61575 A IL 61575A IL 6157580 A IL6157580 A IL 6157580A IL 61575 A IL61575 A IL 61575A
Authority
IL
Israel
Prior art keywords
diunsaturated
hydroxy
acid derivatives
prostanoic acid
prostanoic
Prior art date
Application number
IL61575A
Other languages
English (en)
Other versions
IL61575A0 (en
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Publication of IL61575A0 publication Critical patent/IL61575A0/xx
Publication of IL61575A publication Critical patent/IL61575A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/76Unsaturated compounds containing keto groups
    • C07C59/90Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/76Unsaturated compounds containing keto groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/76Unsaturated compounds containing keto groups
    • C07C59/80Unsaturated compounds containing keto groups containing rings other than six-membered aromatic rings
    • C07C59/82Unsaturated compounds containing keto groups containing rings other than six-membered aromatic rings the keto group being part of a ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/16Radicals substituted by halogen atoms or nitro radicals
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Cosmetics (AREA)
IL61575A 1979-11-28 1980-11-27 4(5),13(14)-diunsaturated 16-hydroxy-prostanoic acid derivatives IL61575A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/098,290 US4271314A (en) 1979-11-28 1979-11-28 4,5-Unsaturated prostanoic acid derivatives

Publications (2)

Publication Number Publication Date
IL61575A0 IL61575A0 (en) 1980-12-31
IL61575A true IL61575A (en) 1984-05-31

Family

ID=22268646

Family Applications (1)

Application Number Title Priority Date Filing Date
IL61575A IL61575A (en) 1979-11-28 1980-11-27 4(5),13(14)-diunsaturated 16-hydroxy-prostanoic acid derivatives

Country Status (23)

Country Link
US (1) US4271314A (xx)
JP (1) JPS5699457A (xx)
AT (1) AT379144B (xx)
AU (1) AU539192B2 (xx)
BE (1) BE886370A (xx)
CA (1) CA1192903A (xx)
CH (1) CH646147A5 (xx)
DE (1) DE3044794A1 (xx)
DK (2) DK504680A (xx)
ES (2) ES8204418A1 (xx)
FI (1) FI71552C (xx)
FR (1) FR2473516A1 (xx)
GB (1) GB2065117B (xx)
GR (1) GR72283B (xx)
IE (1) IE50574B1 (xx)
IL (1) IL61575A (xx)
IT (1) IT1207155B (xx)
NL (1) NL191386C (xx)
NO (1) NO155289C (xx)
NZ (1) NZ195666A (xx)
PT (1) PT72129B (xx)
SE (1) SE436873B (xx)
ZA (1) ZA807415B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4529811A (en) * 1981-03-02 1985-07-16 G. D. Searle & Co. Process for isolating organic compounds and lithium salt complexes useful in said process
US4312994A (en) * 1981-03-25 1982-01-26 G. D. Searle & Co. α Chain dienic prostanoic acid derivatives
US4754059A (en) * 1984-11-07 1988-06-28 G. D. Searle & Co. Omega cycloalkyl prostaglandins
US4499296A (en) * 1983-11-14 1985-02-12 G. D. Searle & Co. Omega cycloalkyl prostaglandins
GB8410396D0 (en) * 1984-04-24 1984-05-31 Glaxo Group Ltd Carbocyclic compounds
US4785124A (en) * 1987-06-08 1988-11-15 G. D. Searle & Co. Process for preparing higher order cuprate complexes
US5011958A (en) * 1987-06-08 1991-04-30 G. D. Searle & Co. Process for preparing higher order cuprate complexes
US4777275A (en) * 1987-06-09 1988-10-11 G. D. Searle & Co. Process of preparing higher order cuprate complexes
US5191109A (en) * 1990-02-02 1993-03-02 Sumitomo Chemical Company, Limited Process for preparing optically active cyclopentenones
US6103765A (en) 1997-07-09 2000-08-15 Androsolutions, Inc. Methods for treating male erectile dysfunction
KR20010021625A (ko) 1997-07-09 2001-03-15 추후보정 개선된 남성발기 기능장애 치료방법 및 그 조성물
US6639111B2 (en) 2000-01-05 2003-10-28 Ono Pharmaceutical Co., Ltd. 5-thia-ω-(substituted phenyl)-prostaglandin E alcohols, process for preparing the alcohols and pharmaceutical preparations containing the same as the active ingredient

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3965143A (en) * 1974-03-26 1976-06-22 G. D. Searle & Co. 16-Oxygenated prostanoic acid derivatives
US4028419A (en) * 1976-01-08 1977-06-07 The Upjoin Company 2-Decarboxy-2-hydroxymethyl-cis-4,5-didehydro-PGE, compounds
GB1595118A (en) * 1977-05-31 1981-08-05 Sumitomo Chemical Co Prostadienoic acids processes for producing them and compositions containing them

Also Published As

Publication number Publication date
IT1207155B (it) 1989-05-17
ES497260A0 (es) 1982-04-01
JPS6366832B2 (xx) 1988-12-22
NL191386C (nl) 1995-07-03
DK613487D0 (da) 1987-11-23
FR2473516A1 (fr) 1981-07-17
PT72129A (en) 1980-12-01
IL61575A0 (en) 1980-12-31
DK613487A (da) 1987-11-23
BE886370A (fr) 1981-05-27
AT379144B (de) 1985-11-25
SE436873B (sv) 1985-01-28
GR72283B (xx) 1983-10-14
ES507577A0 (es) 1982-10-01
IE802471L (en) 1981-05-28
NZ195666A (en) 1982-12-21
AU539192B2 (en) 1984-09-13
FI803685L (fi) 1981-05-29
GB2065117B (en) 1984-09-05
JPS5699457A (en) 1981-08-10
FI71552B (fi) 1986-10-10
NO155289C (no) 1987-03-11
SE8008300L (sv) 1981-05-29
ES8300089A1 (es) 1982-10-01
NO803592L (no) 1981-05-29
DK162281C (da) 1992-03-16
FR2473516B1 (xx) 1983-07-29
NO155289B (no) 1986-12-01
US4271314A (en) 1981-06-02
IT8050259A0 (it) 1980-11-27
GB2065117A (en) 1981-06-24
PT72129B (en) 1981-09-29
DK162281B (da) 1991-10-07
AU6476680A (en) 1981-07-02
ATA579280A (de) 1985-04-15
ES8204418A1 (es) 1982-04-01
IE50574B1 (en) 1986-05-14
CA1192903A (en) 1985-09-03
DE3044794A1 (de) 1981-08-27
NL8006473A (nl) 1981-07-01
DE3044794C2 (xx) 1990-02-15
FI71552C (fi) 1987-01-19
NL191386B (nl) 1995-02-01
CH646147A5 (de) 1984-11-15
DK504680A (da) 1981-05-29
ZA807415B (en) 1982-07-28

Similar Documents

Publication Publication Date Title
YU201180A (en) Process for preparingnew 2,4,6-triiodo-isophalic acid derivatives
GB2035303B (en) 2,3-dicyano-hydroquinone derivatives
PT71744B (en) Substituted beta-carbolin-3-carboxylic acid derivatives
AU2241677A (en) 4,5-dichloroimidazole-2-carboxylic acid derivatives
GB2140016B (en) 1,2-epoxy-3-oxo-chola-4,6-dien-24-oic acid derivatives
GB2041361B (en) 1,2-dihydro-2-oxo-4-phenyl-3-quinolinecarbonitrile derivatives
GB2045757B (en) 1,2,3-thiadiazole-5-carboxylic acid derivatives
GB2067567B (en) 24,24-difluoro-cyclovitamin d3 derivatives
IL61575A (en) 4(5),13(14)-diunsaturated 16-hydroxy-prostanoic acid derivatives
GB2117774B (en) Oximinoacetic acid derivatives
ZA807494B (en) 2,3-indoledione derivatives
AU535236B2 (en) 1,2,3-thiadiazole-5-carboxulic acid amides
AU538454B2 (en) 4,4:-dinitrostilbene-2,2:-disulphonic acid
GB2017093B (en) 3,3-dichloro-2-azetidinone derivatives
IL68879A0 (en) N-substituted-3,4,5,6-tetrahydrophthalamic acid derivatives
AU527930B2 (en) 1,3,4-thiadiazole-2-carboxylic acid derivatives
GB2012266B (en) 1,5 - cyclohexadienecarbocylic acid derivatives
GB2053912B (en) Acylaminobenzoic acid derivatives
GB2093018B (en) 6,8-difluoro-quinoline carboxylic acid derivatives
AU505434B1 (en) 2, 5 diketogluconic acid
IL59681A0 (en) 2,o-dihydro-1,j-bezodioxane derivatives
ZA803734B (en) Acylaminobenzoic acid derivatives
NZ194583A (en) 5,6-dihydro-11h-pyrimido (4,5-6)(1,5) benzodiazepin-5-ones
GB2125035B (en) 6b-halopenicillanic acid derivatives
GB2051781B (en) Oxoamino acid derivatives